NR1H3 and cancer: Next, TIMER, CIBERSORT, CIBERSORT-ABS, QUANTISEQ, XCELL, MCPCOUNTER and EPIC algorithms were further used to validate the potential relation between the expression of NR1H3 and the infiltration level of 8 types of immune cells (B Cells, CD4+ T Cells, CD8+ T Cells, monocytes, macrophages, DCs, neutrophils and NK cells) in diverse cancer types of TCGA.